pH-responsive carbohydrate polymer-based nanoparticles in cancer therapy

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• The tumor microenvironment (TME) presents unique features, including mild acidity, that can be exploited for targeted cancer therapies.
• Developing nanomaterials that respond to these TME characteristics can improve therapeutic efficacy and reduce systemic toxicity.

Purpose of the Study:

• To explore the potential of pH-responsive nanoparticles derived from carbohydrate polymers for enhanced tumor suppression.
• To investigate the application of these smart nanoparticles in targeted drug delivery, combination therapies, and theranostics.

Main Methods:

• Design and synthesis of pH-responsive nanoparticles utilizing carbohydrate polymers.
• Evaluation of nanoparticle response to the acidic TME for controlled cargo release.
• Assessment of biocompatibility and anti-cancer activity of the developed nanomaterials.

Main Results:

• Carbohydrate polymer-based nanoparticles demonstrate pH-responsiveness, enabling targeted release of therapeutics within the TME.
• These nanoparticles show potential for improving selectivity and specificity in cancer treatment.
• The approach offers a strategy to decrease side effects associated with systemic chemotherapy.

Conclusions:

• pH-responsive nanoparticles from carbohydrate polymers are promising for targeted cancer therapy, including combination treatments (chemotherapy, immunotherapy, phototherapy).
• These nanomaterials exhibit theranostic capabilities for simultaneous cancer diagnosis and therapy.
• Further research on large-scale production, biocompatibility, and long-term safety is crucial for clinical translation.